APA (7th ed.) Citation

YZ, W., & YY, C. (2026). Paradox of atropine in myopia control: Exploring dose-dependent efficacy, rebound effects, and optimal risk-benefit balance-a perspective. Frontiers in public health, 14, 1878312. https://doi.org/10.3389/fpubh.2026.1878312

Chicago Style (17th ed.) Citation

YZ, Wu, and Chen YY. "Paradox of Atropine in Myopia Control: Exploring Dose-dependent Efficacy, Rebound Effects, and Optimal Risk-benefit Balance-a Perspective." Frontiers in Public Health 14 (2026): 1878312. https://doi.org/10.3389/fpubh.2026.1878312.

MLA (9th ed.) Citation

YZ, Wu, and Chen YY. "Paradox of Atropine in Myopia Control: Exploring Dose-dependent Efficacy, Rebound Effects, and Optimal Risk-benefit Balance-a Perspective." Frontiers in Public Health, vol. 14, 2026, p. 1878312, https://doi.org/10.3389/fpubh.2026.1878312.